Skip to Content


In the US, Pegaspargase (pegaspargase systemic) is a member of the drug class miscellaneous antineoplastics and is used to treat Acute Lymphoblastic Leukemia.

US matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Therapeutic Category

Antineoplastic agent

Chemical Names

Asparaginase, reaction product wit succinic anhydride, esters wit polyetylene glycol monometyl eter


Foreign Names

  • Pegaspargasum (Latin)
  • Pegaspargase (German)
  • Pegaspargase (French)
  • Pegaspargasa (Spanish)

Generic Names

  • Pegaspargase (OS: USAN)
  • PEG-L-asparaginase (IS)

Brand Names

  • Ai Yang
    Hengrui, China
  • Oncaspar
    Filaxis, Argentina; LENIS, Slovenia; Sigma-tau, Germany


ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.